Tuberculosis and Respiratory Diseases

  • 제78권2호
  • /
  • Pages.64-71
  • /
  • 2015
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

Diagnosis of Pulmonary Tuberculosis: Recent Advances and Diagnostic Algorithms

  • Ryu, Yon Ju (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Ewha Womans University School of Medicine)
  • 투고 : 2015.01.29
  • 심사 : 2015.03.13
  • 발행 : 2015.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Pulmonary tuberculosis (TB) persists as a great public health problem in Korea. Increases in the overall age of the population and the rise of drug-resistant TB have reinforced the need for rapid diagnostic improvements and new modalities to detect TB and drug-resistant TB, as well as to improve TB control. Standard guidelines and recent advances for diagnosing pulmonary TB are summarized in this article. An early and accurate diagnosis of pulmonary TB should be established using chest X-ray, sputum microscopy, culture in both liquid and solid media, and nucleic acid amplification. Chest computed tomography, histopathological examination of biopsy samples, and new molecular diagnostic tests can be used for earlier and improved diagnoses, especially in patients with smear-negative pulmonary TB or clinically-diagnosed TB and drug-resistant TB.

키워드

참고문헌

  1. World Health Organization. Global tuberculosis report 2014 [Internet]. Geneva: World Health Organization; 2014 [cited 2015 Mar 1]. Available from: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?ua=1.
  2. Park YK, Park YS, Na KI, Cho EH, Shin SS, Kim HJ. Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010. Tuberc Respir Dis 2013;74:104-10. https://doi.org/10.4046/trd.2013.74.3.104
  3. World Health Organization. Early detection of tuberculosis: an overview of approaches, guidelines and tools [Internet]. Geneva: World Health Organization; 2011 [cited 2015 Mar 1]. Available from: http://www.who.int/iris/handle/10665/70824#sthash.TN5snAtB.dpuf.
  4. Woodring JH, Vandiviere HM, Fried AM, Dillon ML, Williams TD, Melvin IG. Update: the radiographic features of pulmonary tuberculosis. AJR Am J Roentgenol 1986;146:497-506. https://doi.org/10.2214/ajr.146.3.497
  5. Krysl J, Korzeniewska-Kosela M, Muller NL, FitzGerald JM. Radiologic features of pulmonary tuberculosis: an assessment of 188 cases. Can Assoc Radiol J 1994;45:101-7.
  6. Grossman RF, Hsueh PR, Gillespie SH, Blasi F. Communityacquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones. Int J Infect Dis 2014;18:14-21. https://doi.org/10.1016/j.ijid.2013.09.013
  7. Wang M, Fitzgerald JM, Richardson K, Marra CA, Cook VJ, Hajek J, et al. Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic? Int J Tuberc Lung Dis 2011;15:1062-8. https://doi.org/10.5588/ijtld.10.0734
  8. World Health Organization. Definitions and reporting framework for tuberculosis: 2013 revision (updated December 2014) [Internet]. Geneva: World Health Organization; 2013 [cited 2015 Mar 1]. Available from: http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf?ua=1.
  9. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: National Institute for Health and Clinical Excellence; 2011.
  10. Wilson ML. Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance. Clin Infect Dis 2011;52:1350-5. https://doi.org/10.1093/cid/cir146
  11. Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 2nd ed. Seoul and Cheongwon: Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention; 2014.
  12. International standards for tuberculosis care, 3rd ed [Internet]. The Hague: TB Care 1; 2014. Available from: http://www.who.int/tb/publications/ISTC_3rdEd.pdf?ua=1.
  13. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014;1:CD009593.
  14. Lee KS, Song KS, Lim TH, Kim PN, Kim IY, Lee BH. Adultonset pulmonary tuberculosis: findings on chest radiographs and CT scans. AJR Am J Roentgenol 1993;160:753-8. https://doi.org/10.2214/ajr.160.4.8456658
  15. Geng E, Kreiswirth B, Burzynski J, Schluger NW. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA 2005;293:2740-5. https://doi.org/10.1001/jama.293.22.2740
  16. Jones BE, Ryu R, Yang Z, Cave MD, Pogoda JM, Otaya M, et al. Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med 1997;156(4 Pt 1):1270-3. https://doi.org/10.1164/ajrccm.156.4.9609143
  17. Im JG, Itoh H, Shim YS, Lee JH, Ahn J, Han MC, et al. Pulmonary tuberculosis: CT findings: early active disease and sequential change with antituberculous therapy. Radiology 1993;186:653-60. https://doi.org/10.1148/radiology.186.3.8430169
  18. World Health Organization. Same-day diagnosis of tuberculosis by microscopy: WHO policy statement [Internet]. Geneva: World Health Organization; 2011 [cited 2015 Mar 1]. Available from: http://www.who.int/iris/handle/10665/44603#sthash.gvkTkPOD.dpuf.
  19. Davis JL, Cattamanchi A, Cuevas LE, Hopewell PC, Steingart KR. Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2013;13:147-54. https://doi.org/10.1016/S1473-3099(12)70232-3
  20. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006;6:570-81. https://doi.org/10.1016/S1473-3099(06)70578-3
  21. World Health Organization. Fluorescent light emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement [Internet]. Geneva: World Health Organization; 2010 [cited 2015 Mar 1]. Available from: http://www.who.int/tb/laboratory/who_policy_led_microscopy_july10.pdf.
  22. Kanchana MV, Cheke D, Natyshak I, Connor B, Warner A, Martin T. Evaluation of the BACTEC MGIT 960 system for the recovery of mycobacteria. Diagn Microbiol Infect Dis 2000;37:31-6. https://doi.org/10.1016/S0732-8893(99)00151-0
  23. Greco S, Girardi E, Navarra A, Saltini C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 2006;61:783-90. https://doi.org/10.1136/thx.2005.054908
  24. Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One 2008;3:e1536. https://doi.org/10.1371/journal.pone.0001536
  25. Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009;58:7-10.
  26. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161(4 Pt 1):1376-95. https://doi.org/10.1164/ajrccm.161.4.16141
  27. Kwon YS, Koh WJ. Diagnosis of pulmonary tuberculosis and nontuberculous mycobacterial lung disease in Korea. Tuberc Respir Dis 2014;77:1-5. https://doi.org/10.4046/trd.2014.77.1.1
  28. World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement [Internet]. Geneva: World Health Organization; 2008 [cited 2015 Mar 1]. Available from: http://www.who.int/tb/laboratory/lpa_policy.pdf.
  29. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009;13:1320-30.
  30. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998;79:3-29. https://doi.org/10.1054/tuld.1998.0002
  31. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update [Internet]. Geneva: World Health Organization; 2013 [cited 2015 Mar 1]. Available from: http://www.who.int/iris/handle/10665/112472#sthash.WDSfafG9.dpuf.
  32. Weyer K, Mirzayev F, Migliori GB, Van Gemert W, D’Ambrosio L, Zignol M, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013;42:252-71. https://doi.org/10.1183/09031936.00157212
  33. World Health Organization. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system [Internet]. Geneva: World Health Organization; 2011 [cited 2015 Mar 1]. Available from: http://www.who.int/iris/handle/10665/44586#sthash.Cdd-BEYMy.dpuf.
  34. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-15. https://doi.org/10.1056/NEJMoa0907847
  35. World Health Organization. Xpert MTB/RIF implementation manual: technical and perational 'how-to': practical considerations [Internet]. Geneva: World Health Organization; 2014 [cited 2015 Mar 1]. Available from: http://apps.who.int/iris/bitstream/10665/112469/1/9789241506700_eng.pdf.
  36. Chan HS, Sun AJ, Hoheisel GB. Bronchoscopic aspiration and bronchoalveolar lavage in the diagnosis of sputum smearnegative pulmonary tuberculosis. Lung 1990;168:215-20. https://doi.org/10.1007/BF02719695
  37. Seong GM, Lee J, Lee JH, Kim JH, Kim M. Usefulness of sputum induction with hypertonic saline in a real clinical practice for bacteriological yields of active pulmonary tuberculosis. Tuberc Respir Dis 2014;76:163-8. https://doi.org/10.4046/trd.2014.76.4.163
  38. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2000;4:97-107.
  39. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smearnegative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 2003;3:288-96. https://doi.org/10.1016/S1473-3099(03)00609-1
  40. Lee JJ, Chong PY, Lin CB, Hsu AH, Lee CC. High resolution chest CT in patients with pulmonary tuberculosis: characteristic findings before and after antituberculous therapy. Eur J Radiol 2008;67:100-4. https://doi.org/10.1016/j.ejrad.2007.07.009
  41. Chawla R, Pant K, Jaggi OP, Chandrashekhar S, Thukral SS. Fibreoptic bronchoscopy in smear-negative pulmonary tuberculosis. Eur Respir J 1988;1:804-6.
  42. Lee HS, Park KU, Park JO, Chang HE, Song J, Choe G. Rapid, sensitive, and specific detection of Mycobacterium tuberculosis complex by real-time PCR on paraffin-embedded human tissues. J Mol Diagn 2011;13:390-4. https://doi.org/10.1016/j.jmoldx.2011.02.004
  43. Park JS, Kang YA, Kwon SY, Yoon HI, Chung JH, Lee CT, et al. Nested PCR in lung tissue for diagnosis of pulmonary tuberculosis. Eur Respir J 2010;35:851-7. https://doi.org/10.1183/09031936.00067209
  44. International standards for tuberculosis care. Wkly Epidemiol Rec 2006;81:43-7.
  45. Achkar JM, Sherpa T, Cohen HW, Holzman RS. Differences in clinical presentation among persons with pulmonary tuberculosis: a comparison of documented and undocumented foreign-born versus US-born persons. Clin Infect Dis 2008;47:1277-83. https://doi.org/10.1086/592572
  46. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007;44:69-73. https://doi.org/10.1086/509928
  47. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis 2006;6:710-25. https://doi.org/10.1016/S1473-3099(06)70628-4
  48. Tattevin P, Che D, Fraisse P, Gatey C, Guichard C, Antoine D, et al. Factors associated with patient and health care system delay in the diagnosis of tuberculosis in France. Int J Tuberc Lung Dis 2012;16:510-5. https://doi.org/10.5588/ijtld.11.0420

피인용 문헌

  1. Novel T-Cell Assays for the Discrimination of Active and Latent Tuberculosis Infection: The Diagnostic Value of PPE Family vol.19, pp.5, 2015, https://doi.org/10.1007/s40291-015-0157-0
  2. Mediastinal Tuberculous Lymphadenitis Diagnosed by Endosonographic Fine Needle Aspiration vol.68, pp.6, 2015, https://doi.org/10.4166/kjg.2016.68.6.312
  3. Pulmonary Tuberculosis Diagnosis: Where We Are? vol.79, pp.3, 2016, https://doi.org/10.4046/trd.2016.79.3.134
  4. Discordance between MTB/RIF and Real-Time Tuberculosis-Specific Polymerase Chain Reaction Assay in Bronchial Washing Specimen and Its Clinical Implications vol.11, pp.10, 2015, https://doi.org/10.1371/journal.pone.0164923
  5. Tuberculosis Infection and Latent Tuberculosis vol.79, pp.4, 2015, https://doi.org/10.4046/trd.2016.79.4.201
  6. Effects of Corticosteroids on Critically Ill Pulmonary Tuberculosis Patients With Acute Respiratory Failure: A Propensity Analysis of Mortality vol.63, pp.11, 2016, https://doi.org/10.1093/cid/ciw616
  7. Imaging of thoracic tuberculosis in children: current and future directions vol.47, pp.10, 2015, https://doi.org/10.1007/s00247-017-3866-1
  8. Identification and comparison of novel circular RNAs with associated co-expression and competing endogenous RNA networks in pulmonary tuberculosis vol.8, pp.69, 2015, https://doi.org/10.18632/oncotarget.22710
  9. Down-Regulation of Serum High-Mobility Group Box 1 Protein in Patients with Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease vol.80, pp.2, 2015, https://doi.org/10.4046/trd.2017.80.2.153
  10. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden vol.10, pp.None, 2015, https://doi.org/10.1080/16549716.2016.1264702
  11. Profile of Respiratory and Extra-Respiratory Tuberculosis in Patients Living with HIV in Dolj County between 2005-2015 vol.43, pp.3, 2015, https://doi.org/10.12865/chsj.43.03.06
  12. Identification of specific antibodies against the Ag85C-MPT51-HspX fusion protein (CMX) for serological screening of tuberculosis in endemic area vol.13, pp.8, 2015, https://doi.org/10.1080/1744666x.2017.1345626
  13. Resuscitation-promoting factors are important determinants of the pathophysiology inMycobacterium tuberculosisinfection vol.43, pp.5, 2015, https://doi.org/10.1080/1040841x.2017.1283485
  14. Rapid molecular assays for detection of tuberculosis vol.10, pp.1, 2018, https://doi.org/10.1186/s41479-018-0049-2
  15. Identification of mycolic acid forms using surface-enhanced Raman scattering as a fast detection method for tuberculosis vol.13, pp.None, 2015, https://doi.org/10.2147/ijn.s171400
  16. Active Tuberculosis Is Characterized by Highly Differentiated Effector Memory Th1 Cells vol.9, pp.None, 2015, https://doi.org/10.3389/fimmu.2018.02127
  17. Effectiveness of Contact Tracing of Index Tuberculosis Cases in Nigeria vol.8, pp.4, 2018, https://doi.org/10.4236/aid.2018.84016
  18. Fluorescence & bioluminescence in the quest for imaging, probing & analysis of mycobacterial infections vol.13, pp.8, 2015, https://doi.org/10.2217/fmb-2017-0296
  19. Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis vol.13, pp.7, 2015, https://doi.org/10.1371/journal.pone.0201025
  20. Real-time monitoring of T-cell-secreted interferon-γ for the diagnosis of tuberculosis vol.32, pp.4, 2015, https://doi.org/10.1080/13102818.2018.1432416
  21. Evaluation of FluoroType MTB for direct detection of Mycobacterium tuberculosis complex and GenoType MTBDRplus for determining rifampicin and isoniazid resistance vol.32, pp.4, 2015, https://doi.org/10.1080/13102818.2018.1466662
  22. Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis vol.13, pp.8, 2015, https://doi.org/10.1371/journal.pone.0201748
  23. FISHing Mycobacterium tuberculosis Complex by Use of a rpoB DNA Probe Bait vol.56, pp.10, 2015, https://doi.org/10.1128/jcm.00568-18
  24. Lymph node tuberculosis - The ENT surgeon approach in four cases vol.8, pp.32, 2015, https://doi.org/10.2478/rjr-2018-0028
  25. Development of a high sensitivity TaqMan-based PCR assay for the specific detection of Mycobacterium tuberculosis complex in both pulmonary and extrapulmonary specimens vol.9, pp.None, 2015, https://doi.org/10.1038/s41598-018-33804-1
  26. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13 vol.37, pp.6, 2015, https://doi.org/10.1080/07391102.2018.1462734
  27. Diagnostic Yield of Fluorescence and Ziehl-Neelsen Staining Techniques in the Diagnosis of Pulmonary Tuberculosis: A Comparative Study in a District Health Facility vol.2019, pp.None, 2015, https://doi.org/10.1155/2019/4091937
  28. Nanoparticle-Based Biosensing of Tuberculosis, an Affordable and Practical Alternative to Current Methods vol.9, pp.1, 2015, https://doi.org/10.3390/bios9010001
  29. TUBERCULOSIS AMONG CHILDREN IN SULAIMANI- CLINICAL PATTERN 2014 TO 2017 vol.8, pp.22, 2015, https://doi.org/10.14260/jemds/2019/395
  30. Diagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis vol.82, pp.None, 2015, https://doi.org/10.1016/j.ijid.2019.03.021
  31. ACID-FAST BACILLI CONVERSION OF BEIJING AND NON-BEIJING STRAIN OF PULMONARY TUBERCULOSIS IN SOUTH SULAWESI vol.7, pp.5, 2015, https://doi.org/10.20473/ijtid.v7i5.9670
  32. Evaluation of a manual identification system for detection of Mycobacterium tuberculosis in a primary tuberculosis laboratory in China vol.47, pp.6, 2015, https://doi.org/10.1177/0300060519844399
  33. Same Day Sputum Microscopy for Screening of Pulmonary Tuberculosis: its Accuracy and Usefulness in Comparison with Conventional Method vol.13, pp.2, 2015, https://doi.org/10.22207/jpam.13.2.67
  34. Molecular Bacterial Load Assay Concurs with Culture on NaOH-Induced Loss of Mycobacterium tuberculosis Viability vol.57, pp.7, 2015, https://doi.org/10.1128/jcm.01992-18
  35. Pulmonary tuberculosis with rhinosinusal and otic manifestations - diagnostic challenge vol.9, pp.35, 2015, https://doi.org/10.2478/rjr-2019-0019
  36. Tuberculosis septic shock, an elusive pathophysiology and hurdles in management: A case report and review of literature vol.8, pp.5, 2015, https://doi.org/10.5492/wjcc.v8.i5.64
  37. Tuberculosis septic shock, an elusive pathophysiology and hurdles in management: A case report and review of literature vol.8, pp.5, 2019, https://doi.org/10.5492/wjccm.v8.i5.64
  38. Tuberculosis septic shock, an elusive pathophysiology and hurdles in management: A case report and review of literature vol.8, pp.5, 2015, https://doi.org/10.5492/wjccm.v8.i5.72
  39. Rapid Tuberculosis Diagnosis Using Reporter Enzyme Fluorescence vol.57, pp.12, 2015, https://doi.org/10.1128/jcm.01462-19
  40. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies vol.19, pp.None, 2015, https://doi.org/10.1186/s12879-019-3892-8
  41. Application of serial tests for Mycobacterium tuberculosis detection to active lung tuberculosis cases in Indonesia vol.12, pp.None, 2015, https://doi.org/10.1186/s13104-019-4350-9
  42. Prognostic factors for unfavourable outcomes of patients with spinal tuberculosis in a country with an intermediate tuberculosis burden : a multicentre cohort study vol.b101, pp.12, 2015, https://doi.org/10.1302/0301-620x.101b12.bjj-2019-0558.r1
  43. Comparison of the Genedia MTB/NTM Detection Kit and Anyplex plus MTB/NTM Detection Kit for detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in clinical specimens vol.34, pp.1, 2015, https://doi.org/10.1002/jcla.23021
  44. Current Practices in Ocular Tuberculosis: A Survey of Brazilian Specialists vol.28, pp.2, 2015, https://doi.org/10.1080/09273948.2018.1563705
  45. Computed Tomography Thorax- Role in the Diagnosis of Pulmonary Tuberculosis vol.9, pp.7, 2015, https://doi.org/10.14260/jemds/2020/96
  46. Microscopic Observation Drug Susceptibility (MODS) Assay: A Convenient Method for Determining Antibiogram of Clinical Isolates of Mycobacterium tuberculosis in Ghana vol.8, pp.1, 2015, https://doi.org/10.3390/medsci8010005
  47. Sensor-as-a-Service: Convergence of Sensor Analytic Point Solutions (SNAPS) and Pay-A-Penny-Per-Use (PAPPU) Paradigm as a Catalyst for Democratization of Healthcare in Underserved Communities vol.10, pp.1, 2015, https://doi.org/10.3390/diagnostics10010022
  48. Characteristics of Poor Tuberculosis Treatment Outcomes among Patients with Pulmonary Tuberculosis in Community Hospitals of Thailand vol.102, pp.3, 2015, https://doi.org/10.4269/ajtmh.19-0564
  49. Detection and Quantification of HspX Antigen in Sputum Samples Using Plasmonic Biosensing: Toward a Real Point-of-Care (POC) for Tuberculosis Diagnosis vol.6, pp.5, 2015, https://doi.org/10.1021/acsinfecdis.9b00502
  50. Targeting novel genes for simultaneous detection of five fungal and bacterial agents from BAL samples using multiplex PCR assay vol.39, pp.8, 2015, https://doi.org/10.1007/s10096-020-03879-8
  51. Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases vol.9, pp.10, 2015, https://doi.org/10.3390/biology9100322
  52. Optimization of Lyophilized LAMP and RT-PCR Reaction Mixes for Detection of Tuberculosis vol.4, pp.4, 2015, https://doi.org/10.2478/ebtj-2020-0027
  53. Evaluation of the performance of an in-house duplex PCR assay targeting the IS6110 and rpoB genes for tuberculosis diagnosis in Cameroon vol.20, pp.1, 2020, https://doi.org/10.1186/s12879-020-05523-4
  54. Advances in tuberculous meningitis diagnosis vol.20, pp.12, 2020, https://doi.org/10.1080/14737159.2020.1858805
  55. Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, Chi vol.14, pp.None, 2021, https://doi.org/10.2147/idr.s313717
  56. Host and Bacterial Iron Homeostasis, an Underexplored Area in Tuberculosis Biomarker Research vol.12, pp.None, 2021, https://doi.org/10.3389/fimmu.2021.742059
  57. Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa vol.10, pp.1, 2015, https://doi.org/10.4102/ajlm.v10i1.1229
  58. Computational exploration and anti-mycobacterial activity of potential inhibitors of Mycobacterium tuberculosis acetyl coenzyme A carboxylase as anti-tubercular agents vol.32, pp.3, 2015, https://doi.org/10.1080/1062936x.2021.1882563
  59. Development of a two-step nucleic acid amplification test for accurate diagnosis of the Mycobacterium tuberculosis complex vol.11, pp.1, 2015, https://doi.org/10.1038/s41598-021-85160-2
  60. Comparison of different diagnostic modalities for isolation of Mycobacterium Tuberculosis among suspected tuberculous lymphadenitis patients vol.83, pp.None, 2015, https://doi.org/10.1590/1519-6984.244311